DANBURY, Conn., May 2, 2012 /PRNewswire/ -- Biodel Inc.

CUPERTINO, Calif., June 24, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today reported that Pfizer Inc. (NYSE: PFE) has received a Complete Response Letter from the U.S.

WORCESTER, Mass,, Oct. 5 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) (www.generex.com) announced today a corporate update in a letter to shareholders from Interim President and Chief Executive Officer, Mark Fletcher, addressing management's strategic initiatives for growth.

MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Based on its recent analysis of the pharmaceuticals and biotechnology market, Frost & Sullivan recognizes MannKind Corporation with the 2010 North America Frost & Sullivan Entrepreneurial Company of the Year Award.

Scientists today described a new ultra-rapid acting mealtime insulin (AFREZZAâ„¢) that is orally inhaled for absorption via the lung.